Common Names: garden pea
Biologically synthesized silver nanoparticles show promise in fighting fungal diseases in peas, inhibiting growth and preventing infection spread, suggesting a novel agricultural protection method.
Scientists use CRISPR/Cas9 to edit a gene in pea seeds, resulting in a 99.8% reduction in bitter compounds. Protein levels increase while starch decreases. Potential for improving pea cultivars using this technique is promising but more research is needed for real-world applications.
Researchers studied the diverse bacterial communities on plants to understand their importance for plant health and interactions with insects. They isolated and analyzed eight bacterial genomes from leaf surfaces.
Researchers studied the pea bZIP family, a plant-specific protein involved in important biological processes. Understanding this protein can help with plant improvement and stress response strategies.
Green pea hull extract can relieve nonalcoholic fatty liver disease in mice by reducing fat accumulation and improving antioxidant activity and lipid and glucose metabolism. Vitamin B6 plays a key role in this process, potentially leading to new treatments for NAFLD.
Scientists tested the effectiveness of a new bacterium, Erwinia strain S9, in helping pea plants tolerate tetracycline (TET) exposure. They found that supplementation with Erwinia strain S9 improved plant growth, reduced oxidative stress, and degraded TET. This could be a useful strategy for wastewater treatment or improving crop resistance in irrigation.
Scientists identified and classified 38 members of the heat shock factor gene family in field pea, confirming their role in stress responses and providing insights into their evolutionary relationship and regulatory mechanisms.
Researchers propose reviving Gregor Mendel's pea plants as a model organism to study cell and organ growth. They found that injecting glucose or using gibberellic acid (GA) enhanced growth. This study provides valuable protocols for investigating the role of gibberellins and auxin in plant development.
Plant lectins could be used to combat COVID-19 pandemics by masking the non-glycosylated receptor binding domain of the virus and the corresponding region of the receptor. The ability of plant lectins to interact with the N- and O-glycans present on the spike proteins and their receptors have been analyzed, as well as the in vitro and in vivo anti-COVID-19 activity reported for them. Possible ways for delivery of lectins to block the spikes and/or their receptors are also discussed.